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Abstract
Placental malaria (PM) can lead to poor neonatal outcomes, including low birthweight due to fetal growth restriction (FGR),
especially when associated with local inflammation (intervillositis or IV). The pathogenesis of PM-associated FGR is largely
unknown, but in idiopathic FGR, impaired transplacental amino acid transport, especially through the system A group of
amino acid transporters, has been implicated. We hypothesized that PM-associated FGR could result from impairment of
transplacental amino acid transport triggered by IV. In a cohort of Malawian women and their infants, the expression and
activity of system A (measured by Na+-dependent 14C-MeAIB uptake) were reduced in PM, especially when associated with
IV, compared to uninfected placentas. In an in vitro model of PM with IV, placental cells exposed to monocyte/infected
erythrocytes conditioned medium showed decreased system A activity. Amino acid concentrations analyzed by reversed
phase ultra performance liquid chromatography in paired maternal and cord plasmas revealed specific alterations of amino
acid transport by PM, especially with IV. Overall, our data suggest that the fetoplacental unit responds to PM by altering its
placental amino acid transport to maintain adequate fetal growth. However, IV more profoundly compromises placental
amino acid transport function, leading to FGR. Our study offers the first pathogenetic explanation for FGR in PM.
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Introduction
Pregnant women living in malaria endemic regions are highly
susceptible to malaria, especially in first pregnancies [1,2]. Malaria
in pregnancy is characterized by placental malaria (PM), the
selective accumulation of Plasmodium-falciparum infected erythro-
cytes (IE) in the maternal intervillous blood space of the placenta,
in direct contact with the nutrient-transporting epithelium, the
syncytiotrophoblast. When placental malarial infection is poorly
controlled, chemokine release results in the recruitment of
maternal immune cells, predominantly monocytes, to the intervil-
lous blood spaces [3]. The resultant inflammation is termed
intervillositis (IV) [4]. In comparison to PM without local
inflammation, PM with IV is associated with significant decreases
in birthweight and an increased prevalence of low birthweight
(LBW) deliveries, primarily due to fetal growth restriction (FGR)
[1,2,5,6].
Recent studies have begun to shed light on the pathogenetic
mechanisms linking PM and FGR (reviewed in [7]). Inadequate
maternal nutrition and placental insufficiency have been proposed.
In Congolese women studied by serial ultrasound examinations,
FGR associated with PM was 2–8 times more common in
undernourished than in well-nourished mothers [8]. The same
undernourished mothers with PM had increased uterine artery
resistance (Griffin et al. submitted), which is associated with
placental insufficiency. A decreased fetal/placental weight ratio is
one manifestation of placental insufficiency found in primigravid
women with PM [9].
It has previously been suggested [9,10] that FGR and LBW
associated with PM could be caused by impaired capacity of the
placenta to transport maternal nutrients, especially amino acids, to
the growing fetus. Although this postulate has never been formally
tested, it is supported by observations in idiopathic FGR showing
that the activities of various placental nutrient transporters are
selectively altered [11,12]. Among the nutrient transporters
affected is system A, a group of Na+-dependent neutral amino
acid transporters that actively transfer small, neutral amino acids
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and thereby enables the establishment of high intracellular amino
acid concentrations, which are then used to exchange for
extracellular essential amino acids via system L [13,14].
In the placenta, system A activity is mediated by three Na+-
dependent neutral amino acid transporter (SNAT) isoforms
belonging to the SLC38 gene family; SNAT1 (SLC38A1), SNAT2
(SLC38A2) and SNAT4 (SLC38A4). All isoforms are expressed on
the microvillous plasma membrane (MVM) of the human
syncytiotrophoblast [15]. A reduced system A amino acid
transporter activity in MVM has been consistently observed in
placentas of pregnancies associated with FGR [16–18], and the
reduction in system A activity in MVM correlates well with the
severity of FGR [19]. Further, various animal studies have
suggested that reduced system A activity may be causally related to
the etiology of FGR [20–22].
Pro-inflammatory cytokines produced by monocytes have been
shown to decrease system A activity. IL-1b reduces system A
activity in trophoblast cells [23] and acute exposure to TNF-a
resulted in diminished maternofetal transfer of a system A
analogue in a rat model of FGR [24]. These cytokines have been
associated with LBW in PM, especially when associated with IV
[25–27], and their production could be caused by PM, either
through activation of monocytes by IE [28] or by direct effects of
IE on syncytiotrophoblast leading to secretion of cytokines and
chemokines [29,30]. This suggests a link between PM, IV and
altered placental amino acid transport, with impacts on fetal
growth and development.
In the current study, we hypothesized that the release of soluble
mediators triggered by IV associated with PM impairs placental
transport of amino acids across the syncytiotrophoblast, contrib-
uting to the pathogenesis of FGR and LBW. We found that PM,
especially with IV, was associated with decreased placental amino
acid uptake and dysregulated maternofetal amino acid balance,
likely to alter the transfer of amino acids to the fetus, and to
contribute to the pathogenesis of PM-associated FGR.
Results
Participants’ characteristics
Characteristics of the individuals who participated in the various
aspects of the study are summarized in Table 1.
SLC38A1 and SLC38A2 transcript levels are altered in
placental malaria with intervillositis
SLC38A1 transcript levels were reduced (p= 0.008) in the
syncytiotrophoblast of infected placentas with IV compared to that
of uninfected placentas, while levels in syncytiotrophoblast of
infected placentas without IV were intermediate. A similar trend
was observed for SLC38A2 transcript levels (Fig. 1A). SLC38A1
(p = 0.017) but not SLC38A2 (p = 0.39) transcript levels were lower
in the syncytiotrophoblast of placentas of LBW infants compared
to normal birthweight infants (Fig. 1B).
Amino acid uptake is reduced in placental malaria with
intervillositis
Figure 2A reveals that Na+-dependent MeAIB uptake by MVM
vesicles from infected placentas either with or without IV was
lower (p#0.015) than uptake by vesicles from uninfected
placentas. Na+-dependent MeAIB uptake was similar between
groups with PM (p=0.65). Birthweight was positively associated
with Na+-dependent MeAIB uptake by MVM vesicles from all
placentas (Rho=0.26, p = 0.07; Fig. 2B).
IL-1b concentration is elevated in placental malaria with
intervillositis
In response to P. falciparum infection, monocytes elicit a pro-
inflammatory response including the secretion of IL-1b [28]. IL-
1b has been previously reported to decrease Na+-dependent
MeAIB uptake by placental trophoblast cells [23]. We therefore
investigated whether PM with IV was associated with increased
IL-1b concentration and if conditioned medium from a mono-
cyte/IE co-culture could impair Na+-dependent MeAIB uptake.
IL-1b plasma concentration in maternal blood harvested from
placentas with PM and IV was higher (p = 0.017) compared to
uninfected controls, and comparable (p = 0.1) to the PM without
IV group (Fig. 3A). Within the group of PM with IV, IL-1b
concentration was negatively correlated with birthweight
(Rho=20.52; p = 0.04; Fig. 3B).
IE stimulate monocytes to secrete factors that decrease
amino acid uptake by BeWo cells
Because IL-1b is produced by monocytes in response to IE [28]
and because Na+-dependent MeAIB uptake by MVM vesicles was
lowest in PM with IV (Fig. 2A), we speculated that system A
activity impairment could be attributable to products generated by
monocytes in response to IE.
Medium collected from a monocyte/IE co-culture was used to
mimic the intervillous space milieu in cases of PM with IV. This
medium was applied to human placental choriocarcinoma BeWo
cells to investigate its effect on Na+-dependent MeAIB uptake. Cell
viability was monitored in all subsequent experiments and was
unaffected by any of the treatments (data not shown).
An inhibition of Na+-dependent MeAIB uptake by BeWo cells
when exposed to monocyte/IE co-culture conditioned media was
consistently observed (Fig. 4A). An IL-1b blocking antibody was
used to investigate the role of IL-1b in mediating this effect
(Fig. 4B). At the concentration used, the blocking antibody was
effective in abolishing recombinant IL-1b-mediated reduction in
Na+-dependent MeAIB uptake. In contrast, addition of IL-1b
Author Summary
Malaria infection during pregnancy can cause fetal growth
restriction and low birthweight associated with high infant
mortality and morbidity rates. The pathogenesis of fetal
growth restriction in placental malaria is largely unknown,
but in other pathological pregnancies, impaired transpla-
cental amino acid transport has been implicated. In a
cohort of Malawian women and their infants, we found
that placental malaria, especially when associated with
local inflammation, was associated with decreased expres-
sion and activity of an important group of amino acid
placental transporters. Using an in vitro model of placental
malaria with local inflammation, we discovered that
maternal monocyte products could impair the activity of
amino acid transporters on placental cells. Amino acid
concentrations in paired maternal and cord plasmas
revealed specific alterations of amino acid transport by
placental malaria, especially with local inflammation.
Overall, our data suggest that, more than malaria infection
per se, the local inflammation it triggers compromises
placental amino acid transport function, leading to fetal
growth restriction. Greater understanding of the mecha-
nisms involved, combined with interventions to improve
fetal growth in malaria, are important priorities in areas of
the world where the co-existence of malaria and maternal
malnutrition threatens the health and lives of millions of
young babies.
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Table 1. Participants’ characteristics.
Uninfected Malaria alone Malaria with intervillositis Kruskal-Wallis’ test
SLC38A1 AND SLC38A2 mRNA expression
N 21 11 21
Gestational Age 40 39 39 0.31
(in weeks) (39–40) (35–41) (36–41)
Age 20 23 21 0.085
(in years) (16–29) (18–29) (15–27)
Gravidity 1 3 1 0.081
(1–3) (1–4) (1–5)
Maternal Hb 11 10.8 11 0.85
(in g/dL) (8.7–15.2) (7.6–12.9) (6–14)
Fetal weight 3100 3135 2925 0.039A
(in grams) (2500–4200) (2500–3700) (2000–3650)
Maternal weight at 57.5 56 55 0.91
enrolment (in kg) (50–100) (44–69) (44–75)
MeAIB uptake
N 18 14 21
Gestational Age 40 40.5 39 0.073
(in weeks) (38–40) (35–50) (36–41)
Age 18 18 18 0.63
(in years) (16–23) (16–33) (16–24)
Gravidity 1 1 1 0.43
(1–3) (1–3) (1–2)
Maternal Hb 12.8 11.8 10.9 0.038B
(in g/dL) (9–15.1) (4–13.8) (3.3–14.1)
Fetal weight 3050 2925 2800 0.15C
(in grams) (2600–3800) (2200–3200) (2100–4100)
Maternal weight at 57.5 58 52 0.048D
enrolment (in kg) (45–69) (56–60) (46–60)
Free Amino Acid Analysis
N 31 11 28
Gestational Age 40 40 38 0.24
(in weeks) (36–42) (35–41) (36–42)
Age 18 19 18.5 0.75
(in years) (16–23) (16–25) (16–24)
Gravidity 1 1 1 1E
(1–1) (1–1) (1–1)
Maternal Hb 13 11.8 10.75 0.0004B
(in g/dL) (9–16.1) (10–15.8) (6.7–13.4)
Fetal weight 3000 2900 2800 0.28
(in grams) (1990–3800) (2200–3600) (2000–4100)
Placental weight 500 500 510 0.90
(in grams) (340–650) (400–620) (300–730)
Fetal to placental 6 5.85 5.41 0.11F
weight ratio (4.14–8.23) (4.49–7.25) (3.81–7.67)
Maternal weight at 55 54 53 0.75
enrolment (in kg) (42–70) (48–60) (45–60)
Data are shown as median (interquartile range).
AInfants born of mothers with PM and IV were lighter than those born of mothers in the two other groups.
BMothers with PM and IV had lower Hb concentration than uninfectedmothers or mothers with PMwithout IV. Thematernal Hb concentration in the latter two groups did not differ.
CThere was a trend for a decreased foetal weight across groups (p = 0.053).
DMothers with PM with IV were lighter than mothers with PM without IV and than uninfected mothers. Maternal weight at enrolment did not differ between uninfected
mothers and mothers with PM without IV.
EOnly primigravidae were recruited in this study.
FPM with IV cases had lower foetal/placental weight ratio than uninfected controls (p = 0.036).
doi:10.1371/journal.ppat.1003153.t001
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blocking antibody had no effect on the inhibition of Na+-
dependent MeAIB uptake observed with monocyte/IE condi-
tioned media. This indicated that IL-1b was not a major factor in
the reduction in Na+-dependent MeAIB uptake observed with
monocyte/IE conditioned media.
Treatment of BeWo cells with uninfected erythrocytes (UE) or
with lysed or intact IE that had or had not been opsonized by human
Ig did not alter Na+-dependent MeAIB uptake by BeWo cells
compared to media control (p$0.12; data not shown). This suggests
that the reduction in Na+-dependent MeAIB uptake by BeWo cells
relies on monocytes’ response to IE more than effects of IE per se.
Placental malaria selectively alters fetal-maternal amino
acid interrelationships
We next investigated the potential effect of altered system A
activity, indicated by the reduced Na+-dependent MeAIB uptake
observed in PM with IV, on fetal amino acid levels by measuring
free amino acid concentration in paired maternal and cord plasma
samples (Table 2).
Maternal concentrations. In mothers with PM without IV,
plasma concentration of Asn, Asp, Cys and Trp was higher
(p#0.037) than in uninfected mothers. Plasma concentration of
Asp, Leu, Phe and Val was higher (p#0.022) and Ala concentra-
Figure 1. SLC38A1 and SLC38A2 mRNA expression in syncytiotrophoblast and relationship to birthweight. Expression of mRNA for the
amino acid transporters SLC38A1 and SLC38A2 was quantified in the laser-captured syncytiotrophoblast of placental biopsies by real time qPCR and
expressed normalized to the housekeeping gene YWHAZ. A. SLC38A1 mRNA expression in placental malaria (PM) with intervillositis (IV; n = 21) was
lower than in uninfected placentas (n = 21; p = 0.008). SLC38A1 transcript levels in placental malaria without intervillositis (n = 11) were intermediate
and similar to that in uninfected placentas (p = 0.46) and to that in infected placentas with IV (p = 0.23). A similar profile was observed for SLC38A2
mRNA expression comparing expression in infected placentas with IV and uninfected placentas. B. Placentas from infants born with a low
birthweight (regardless of infection status; n = 7) had lower SLC38A1 (p = 0.017) but similar SLC38A2 (p = 0.39) transcript levels compared to those
born with a normal birthweight (n = 46). Data shown were obtained in an experiment run in triplicate.
doi:10.1371/journal.ppat.1003153.g001
Figure 2. Amino acid uptake and relationship to placental malaria and birthweight. MVM was purified from uninfected placentas (n = 18)
and infected placentas without (n = 14) or with (n = 22) intervillositis (IV) and Na+-dependent MeAIB uptake was quantified in duplicate. A. Na+-
dependent MeAIB uptake by MVM vesicles from infected placentas both with or without IV was significantly lower compared to that of uninfected
placentas. Na+-dependent MeAIB uptake by MVM of infected placentas with or without IV was not significantly different (p = 0.65). Data are
represented as median (horizontal line), interquartile range (box) and 5th/95th centiles (whiskers). B. Correlation between Na+-dependent MeAIB
uptake by MVM vesicles and birthweight (n = 49; Rho= 0.26; p = 0.07). Uninfected women are represented by#, placental malaria (PM) without IV by
% and PM with IV by D.
doi:10.1371/journal.ppat.1003153.g002
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tion lower (p = 0.003) in women with PM and IV than in
uninfected mothers.
Fetal concentrations. In the group of PM without IV, cord
concentrations of certain amino acids (Asn, Gly, Leu, Phe and
Trp: p#0.081), especially Asp (p = 0.028) and Glu (p= 0.026) were
increased compared to babies of uninfected women (all other
amino acid cord concentrations were similar between the two
groups; p$0.19). In contrast, when PM was associated with IV,
cord concentrations of most amino acids were similar to, or lower
than (p#0.093; Ala and Met), those of the uninfected group, with
the exceptions of Leu, Phe and Val for which cord concentrations
were higher (p#0.046) in the PM with IV group compared to
Figure 3. IL-1b placental plasma concentration and relationship to birthweight. A. IL-1b concentration in plasma sampled from blood of
infected placentas with intervillositis (IV; n = 16) was higher (p = 0.017) than that of uninfected placentas (n = 31). IL-1b concentration in infected
placentas without IV (n = 16) was intermediate and similar to concentrations in infected placentas with IV (p = 0.1) and to concentrations in
uninfected placentas (p = 0.39). Data are represented as median (horizontal line), interquartile range (box) and 5th/95th centiles (whiskers). The ELISA
was performed in duplicate. B. IL-1b concentration in plasma sampled from blood of infected placentas with intervillositis showed a negative
correlation with birthweight (n = 16; Rho=20.52; p = 0.04).
doi:10.1371/journal.ppat.1003153.g003
Figure 4. In vitromodel of amino acid uptake by placental cells. A. BeWo cells incubated for 16 h with the conditioned medium from an IE/
monocyte co-culture showed a marked decrease in Na+-dependent MeAIB uptake relative to cells incubated with an uninfected erythrocyte (UE)/
monocyte conditioned medium (n= 5 independent donors in triplicate). B. BeWo cells were treated for 16 h with either recombinant IL-1b (5 ng/mL)
or conditioned media from UE/monocyte or IE/monocyte co-culture in the presence (grey bars) or absence (open bars) of IL-1b blocking antibody
(BA) (1.25 mg/mL) and Na+-dependent MeAIB uptake measured. Data are expressed as mean + SD (n = 2 independent experiments in triplicate). Effect
of the BA was tested using a one-sided two-sample T-test.
doi:10.1371/journal.ppat.1003153.g004
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Table 2. Maternal and cord amino acid concentration.
Uninfected (n=31) PM without IV (n =11) PM with IV (n=28)
Maternal levels Cord levels Maternal levels Cord levels Maternal levels Cord levels
(mM) (mM) (mM) (mM) (mM) (mM)
Non essential AA
Alanine 387.19BBB 584.66BB 319.62 510.25 295.14 464.59
(301.2–438.72) (458.74–685.69) (250.66–354.37) (478.85–754.49) (213.38–358.48) (396.84–557.17)
Arginine 23.9 48.39 24.55 48.3 28.28 47.79
(19.83–39.85) (33.48–69.61) (14.87–26.59) (30.83–79.52) (20.46–38.63) (38.15–59.75)
Asparagine 25.66AA 51.01A 29.17 55.78 24.97 52.01
(21.34–28.84) (44.4–57.45) (23.85–33.47) (42.41–97.69) (20.26–33.09) (45.07–68.58)
Aspartic acid 7.82AA,BB 30.74AA 9.97 35.46C 9.32 29.05
(4.91–8.98) (15.32–37.41) (9.26–12.12) (17.74–128.17) (7.89–13.3) (13.91–54.83)
Cystine 5.8AA 24.05 9.69C 24.38 6.87 21.07
(4.35–8.08) (18.49–34.12) (8.15–14.99) (16.33–40.88) (4.33–9.53) (17.02–27.61)
Glutamic acid 57.23 180.16AA 63.07 253.06C 47.75 153.32
(44.86–78.64) (126.76–233.05) (46.3–79.45) (116.1–603.27) (41.56–72.26) (113.26–243.11)
Glutamine 373.47 587.38 400.77 529.58 376.39 551.4
(314.88–452.59) (515.16–663.18) (340.06–442.36) (500–754.6) (304.86–468.22) (486.81–686.83)
Glycine 130 264.17A 125.43 313.28 118.76 283.75
(98.37–148.81) (240.36–328.57) (107.69–143.34) (236.6–399.44) (96.48–135.31) (233.35–350.15)
Proline 136.16 200.91 146.15 236.93 150.53 218.55
(116.3–160.3) (178.81–230.77) (132.4–189.45) (169.67–269.92) (122.2–174.31) (184.3–276.45)
Serine 72.81 139.12 77.09 135.57 75.53 128.23
(60.88–87.44) (123.79–163.95) (63.16–89.33) (117.59–217.13) (62.53–87.69) (118.49–160.1)
Tyrosine 36.56 78.75 36.8 73.05 35.23 70.84
(32.92–43.1) (68.12–86.43) (30.8–44) (65.96–96.54) (30.34–42.56) (59.06–85.63)
Essential AA
Histidine 58.22 93.72 60.28 83.3 57.52 94.69
(48.19–66.74) (85.42–102.77) (56.03–69.09) (80.66–108.18) (47.26–68.38) (82.02–105.39)
Isoleucine 31.78 61.57 34.46 77.1 34.22 65.33
(27.11–36.4) (54.66–75.37) (29.19–39.11) (50.01–83.8) (26.8–42.53) (51.87–78.01)
Leucine 62.19BB 128.19AA,BB 66.15 145.77 78.64 143.38
(55.99–78.88) (109.2–149.33) (62.36–81.59) (99.8–209.07) (60.01–93.25) (106.89–179.13)
Lysine 74.96 242.63 78.24 232.63 88 266.57
(64.46–92.91) (210.63–281.02) (61.61–117.25) (183.25–294.91) (69.21–114.05) (186.11–311.82)
Methionine 18.14 34.73B 16.45 36.6C 18.55 30.67
(14.56–23) (29.37–38.73) (14.73–23.92) (30.28–41.8) (14.31–22.05) (26.58–37.47)
Phenylalanine 37.78BBB 83.98AA,BBB 39.42 91.58 47.72 92.39
(35.11–44.69) (72.29–89.41) (35.72–53.66) (77.14–122.06) (39.37–59.26) (79.22–115.6)
Threonine 93.89 176.51 107.22 176.59 101.9 180.12
(73.61–111.96) (147.92–198.51) (88.14–121) (155.41–221.22) (78.83–117.47) (146.41–207.05)
Tryptophan 4.13AAA 5.53AAA 6.47 9.66CCC 5.32 6.08
(2.81–6.16) (4.09–7.72) (3.81–12.78) (6.75–15.51) (3.78–8.1) (4.21–7.65)
Valine 93.51BBB 194.54BBB 102.62 232.04 114.8 217.62
(84.33–101.04) (168.31–216.49) (80.17–127.46) (157.56–234.44) (93.84–136.63) (186.64–261.6)
Total AA 1744.68 3263.84A 1741.41 3353.38 1806.95 3128.61
(1478.9–1917.1) (2872.7–3625) (1566.2–2043.2) (2692.9–4092.5) (1441.8–1965.5) (2828.7–4026.6)
Free amino acid concentration was quantified (in duplicate) in paired maternal and cord blood samples and expressed as median (interquartile range). PM: Placental
malaria; IV: intervillositis. Key to statistical analysis:
A =Uninfected versus PM without IV;
B = Uninfected versus PM with IV;
C = PM without IV versus PM with IV. One symbol = 0.05,p#0.1; two symbols = 0.01,p#0.05; three symbols = p#0.01.
doi:10.1371/journal.ppat.1003153.t002
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uninfected controls. As noted above, maternal concentrations for
these three amino acids were also higher in PM with IV, and given
the tight correlations between cord and maternal concentrations of
these amino acids (p#0.02; Rho$0.33) in this group, the elevated
cord concentration could be driven by the high maternal
concentration. There was no correlation between cord and
maternal concentrations in the uninfected group for these amino
acids (p$0.32). Overall, these data suggest that PM alone and PM
with IV are each associated with altered concentrations of particular
amino acids in cord blood, suggesting specificity of response.
Fetal-maternal concentration ratio. Fetal cord concentra-
tions were higher than maternal concentrations (p#0.05) for all
amino acids in all groups except for Trp. Uninfected placentas
were able to concentrate Trp (Median= 1.27; IQR 1.01–1.63;
p = 0.0009) whereas placentas with PM with IV could not
(Median= 1.24; IQR 0.84–1.62; p = 0.18). Placentas with PM
without IV showed an intermediate phenotype (p = 0.065).
Placental malaria, placental insufficiency and amino acid
transport
A low fetal/placental weight ratio is a marker of placental
insufficiency and has been associated with malaria [9,31,32] and
PM with IV cases had lower fetal/placental weight ratio than
uninfected controls (p = 0.036). For a number of amino acids, cord
concentration was positively correlated with fetal/placental weight
ratio, either among all PM cases or for those with IV (Table 3).
Among babies with PM and IV, cord concentrations of several
neutral, branched chain amino acids, transported by system L [13]
were positively associated with fetal/placental weight ratio. This
suggests that intervillositis may lead to placental insufficiency in
part through impaired transplacental amino acid transport. There
was no positive correlation between cord concentration of amino
acids and birthweight (p$0.29).
Discussion
Understanding the pathogenesis of PM-associated FGR is critical
to the design of novel interventions to decrease its burden [33]. In
this study, we identified an impaired placental amino acid uptake
and dysregulated maternofetal amino acid balance in PM, especially
with IV, providing a pathogenic mechanism for PM-associated
FGR through altered transfer of amino acids to the fetus.
The activities of various transport mechanisms in the plasma
membranes of the syncytiotrophoblast are dysregulated in
Table 3. Correlations between fetal/placental weight ratio and amino acid concentration in PM samples.
Uninfected controls
Placental malaria (with or without
intervillositis) Placental malaria with intervillositis
Maternal levels Cord levels Maternal levels Cord levels Maternal levels Cord levels
Non essential AA
Alanine 0.31+ 0.37++
Arginine 0.46+++
Asparagine 0.34++
Aspartic acid
Cystine
Glutamic acid
Glutamine 0.33++
Glycine
Proline
Serine 0.4++
Tyrosine 0.41++
Essential AA
Histidine 0.81+++ 0.37++
Isoleucine 0.37++ 0.41++
Leucine 0.38++
Lysine 0.55+ 0.32++
Methionine 0.33++
Phenylalanine
Threonine
Tryptophan 0.32++ 0.39++
Valine
Total AA 0.37++ 0.43++
Correlations (Spearman’s rank test) between either cord or maternal amino acid concentration or their ratio and fetal/placental weight ratio (a marker of placental
insufficiency) are summarized. Key to statistical analysis:
+= 0.05,p#0.1;
++= 0.01,p#0.05;
+++=p#0.01;
all with a Rho$0.3.
doi:10.1371/journal.ppat.1003153.t003
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idiopathic FGR [34,35]. In particular, the activity of system A
amino acid transporters has often been reported to be downreg-
ulated in FGR [17–19], and animal studies demonstrate that a
reduction in system A activity precedes development of FGR [22].
We observed reduced transcription of the system A transporters
SLC38A1 (SNAT1), and, to a lesser extent SLC38A2 (SNAT2),
within the syncytiotrophoblast in PM with IV, which is compatible
with the reduction we observed in system A activity, and consistent
with the involvement of these two SNAT subtypes in the
downregulation of system A activity associated with PM with IV.
Previous studies of idiopathic FGR have not demonstrated altered
SLC38A1 or SLC38A2 transcription in whole placental lysates [36],
whereas here we have specifically measured SLC38A1 and
SLC38A2 transcript levels from the syncytiotrophoblast. Our data
suggest that in cases of PM with IV, the syncytiotrophoblast
responds to infection and inflammation by down-regulating the
transcription of these SNAT isoforms. As activity of SNATs is
partly regulated at the level of transcription [37], this suggests that
PM with IV may decrease SNAT-mediated placental amino acid
transport.
To investigate this further, we studied system A activity ex vivo.
System A activity was decreased in PM alone, and to a greater
extent in PM with IV. The relationships observed between PM or
birthweight with system A activity and SNAT transcript levels
suggest that system A makes important contributions to fetal
growth, and that these contributions are compromised by PM,
especially PM with IV.
To understand how PM, especially with IV, might impair
placental amino acid transport we developed an in vitro model to
examine trophoblast cell responses to factors present in the
placental intervillous blood space. Regardless of the way they were
presented to placental cells, IE alone did not induce a significant
decrease in system A-mediated MeAIB uptake. This is in accord
with our ex vivo data, and with clinical observations that PM
without IV is not associated with FGR [6]. In contrast,
conditioned media from monocyte-IE co-cultures, which mimic
the intervillous milieu in PM with IV, significantly reduced MeAIB
uptake by trophoblast cells, indicating that monocytes participated
in eliciting this response. Our evidence suggests that IE activate
monocytes to release factors that inhibit system A activity.
A number of factors have been shown to modulate system A
activity in placental cells or BeWo layers including cytokines such
as IL-1b, IL-6 and TNF-a [23,38] which are increased in PM [25–
27] and produced by monocytes in response to IE [28]. Despite
IL-1b concentrations being raised in maternal blood of the
intervillous space in PM with IV and negatively correlating with
birthweight in this group, the decreased Na+-dependent MeAIB
uptake by BeWo cells in our in vitro model was not substantially
mediated by IL-1b, as illustrated by the inability of blocking
antibody to IL-1 b to counteract the inhibitory effect of monocyte-
IE co-culture supernatants; the mediator(s) responsible are at
present unknown and could either be a factor(s) consumed by
malaria-stimulated monocytes or a factor(s) secreted by these cells.
The cause of the decreased amino acid uptake observed ex vivo
in MVM from women with PM and IV is not known. As discussed
above, it may be mediated by monocyte-derived factors, but these
remain to be conclusively identified. Hormones that stimulate
system A-mediated amino acid uptake including IGFs [39] and
leptin [40] are decreased in PM [41,42], and these may contribute
in part to the decreased system A activity demonstrated in patient
samples. In vitro, supernatants from co-cultures (rather than
monocytes themselves) inhibit amino acid uptake, suggesting that
local depletion of available amino acids by activated monocytes is
not a significant contributing factor.
We next assessed whether the observed decrease in system A
activity in PM, or effects of PM on other amino acid transport
systems, resulted in altered amino acid concentrations in maternal
and cord blood. In normal pregnancy, delivery of some amino
acids, particularly essential amino acids, is only just sufficient to
meet fetal requirements [43,44]. In pregnancies compromised by
severe FGR, maternofetal transfer of amino acids may be reduced
[45,46]. In PM without IV, maternal concentration of a number of
amino acids (Asn, Asp, Cys and Trp) was increased compared to
uninfected controls, possibly due to reduced uptake of these amino
acids by the syncytiotrophoblast, resulting in increased maternal
concentrations. In PM with IV, maternal concentration of all
amino acids except Ala was either unchanged or elevated
compared to uninfected controls, consistent with observations in
idiopathic FGR [46]. Cord Ala levels were also lower compared to
uninfected controls and positively correlated with maternal levels
in PM with IV (Rho=0.56; p = 0.002). Thus, malaria-related
inadequate maternal concentrations of amino acids were not
responsible for changes in fetal amino acid concentrations.
We did not see widespread decreases in cord amino acid
concentration in the group with PM and IV, as have been
described in idiopathic FGR [19,45]. This lack of widespread
impact of PM on cord amino acid concentration could be
explained by the degree of severity of the FGR in our study
compared to the idiopathic FGR studies. In the latter, birthweight
was dramatically decreased, by ,600 g to ,1550 g. In contrast,
in our cohort, birthweight of control infants was relatively low, and
birthweight only differed by ,200 g between control infants and
those with PM and IV (in keeping with larger epidemiological
studies in this population [5,27]). In resource-poor settings such as
Malawi, obstetric care is limited, and women with at risk
pregnancies due to highly compromised placental function and
severe FGR may not be identified for intensive management, but
may instead experience pregnancy loss. Malaria is a common
cause of stillbirth and miscarriage in such settings [47,48], and our
study design may have resulted in malaria-affected pregnancies
with severe FGR being under-represented in our cohorts.
Longitudinal studies of at-risk pregnancies may be useful in
quantifying the risks and manifestations of severe FGR in malaria-
affected pregnancies further.
Differences in cord blood amino acid concentrations between
groups suggest that placental transport and/or metabolism of a
number of amino acids is altered in PM. In the PM without IV
group, the neutral and anionic classes of amino acids were most
notably affected, suggesting a selective effect on placental handling
of these amino acids. In infected women without IV but not in the
group with PM with IV, there was a particularly striking increase
in the fetal concentration of the anionic amino acids Asp and Glu,
which are taken up into the placenta from the maternal and fetal
circulations respectively by system XAG
2. The physiological
significance of this is unclear at present and it could suggest that
IV restored placental transport of these amino acids. However, it is
known that Glu uptake from the fetal circulation plays a crucial
role in fetoplacental Glu-Gln cycling and may also serve to protect
the fetus against Glu neurotoxicity [49]. The similar trend
observed for Asn, Gly, Met (system A substrates) and both Met
and Leu (system L substrates) also implicates these systems as being
affected differentially in PM without IV as against PM with IV.
Whether this reflects altered amino acid transport and/or
placental amino acid utilization or production has yet to be
established. The decrease in system A activity could also indirectly
impair the activity of other systems that depend on the gradient of
amino acid concentration established by system A for their own
activity.
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Trp was the only amino acid for which there was a failure to
concentrate in cord blood as compared to maternal, in the PM
with IV group. In idiopathic FGR, Trp concentration occurs [45]
implying that the failure of Trp to concentrate in our cases was
related to the presence of PM rather than FGR per se. Other
essential amino acids (Ile, Leu, Phe, Thr, Val), which, like Trp, are
transported predominantly by system L [50], were concentrated in
cord blood as compared to maternal, suggesting that there was no
global impairment of system L activity. In placental infections, Trp
is catabolised through the kynurenine pathway, notably by the
enzyme indoleamine 2,3 dioxygenase [51], and we speculate that
similarly increased placental catabolism of Trp in PM contributes
to the lack of Trp placental concentrative capacity we observed.
Cord Trp concentration was increased in PM without IV,
suggesting that Trp placental catabolism may be reduced with
acute infection; a change that is then blocked by inflammatory
cells in chronic infection.
Taken together, our data suggest that PM alters placental
function through effects on multiple amino acid transporter
systems, and that these effects are selective for certain amino acids;
PM may also increase placental amino acid metabolism. In PM
with IV, the dysregulation of maternofetal amino acid concentra-
tions is more pronounced, possibly because the monocytes
accumulating in the intervillous space release inflammatory
mediators that alter the activity of amino acid transporters in
the syncytiotrophoblast.
We have shown effects of PM on one amino acid transport
system, system A, in vitro and ex vivo, and found clues for the
dysregulation of other placental amino acid transport systems.
Amino acid transport is highly complex, with overlapping and
interdependent pathways. Although the defects we observed in
amino acid transporter activity did not translate directly into lower
fetal amino acid concentrations in women with PM and IV, we did
observe important correlations in women with PM, or PM and IV,
between low fetal/placental weight ratio, an index of placental
insufficiency, and low cord levels of critical amino acids. Our
evidence calls for studies to further characterize the effects of PM
and IV on the activity of system A as well as investigating the
activities of systems XAG
2 and L in the placenta. Such studies
should also capture whether PM with IV alters transplacental
transport of glucose [52] or lipids which, together with amino
acids, form essential substrates for fetal growth [53,54].
In order to counteract the decrease in placental nutrient
transport, nutrient supplementation interventions [55] could be
implemented, but should ideally be combined with further
research to ensure that such interventions correct, and do not
exacerbate [56], defects in transport and fetal growth [57].
Greater understanding of the mechanisms by which PM affects
placental nutrient transport, combined with possible interventions
to improve fetal growth in malaria, are important priorities in
areas of the world where the co-existence of malaria and maternal
malnutrition threaten the health and lives of millions of young
babies.
Materials and Methods
Recruitment of participants
From 2001–2006, pregnant women delivering a live singleton
newborn in the labor ward of Queen Elizabeth Central Hospital,
Blantyre, Malawi were recruited into a case-control study. Cases
were defined by the presence of P. falciparum asexual parasites on
placental blood smear. For each case identified, two uninfected,
age (62 years) and gravidity-matched controls, negative for
malaria parasites by both peripheral and placental smears, were
then enrolled. Inclusion and exclusion criteria have been described
elsewhere [41]. The College of Medicine Research Ethics
Committee, University of Malawi, approved the study and written
informed consent was obtained from all participants. Immediately
after delivery maternal and cord venous blood were collected and
separated by centrifugation. Plasma was stored at 280uC.
One set of placental biopsies was snap-frozen in liquid nitrogen
for MVM purification, another set was embedded in optimal
cutting temperature (OCT) medium before being frozen at280uC
for laser capture microdissection (LCM) of the syncytiotrophoblast
and a last set was fixed in 10% neutral-buffered formalin for
malaria infection grading. Placental tissue sections were examined
by light microscopy for presence of malaria infection. In infected
placentas, 500 randomly-selected intervillous space maternal
blood cells were counted as previously described [5], to derive
estimates of placental parasite density and monocyte counts
(expressed as percentage of all maternal intervillous cells).
Sample selection
Samples used in the study were selected from the cohort of
participants based on tissue availability, after assessment of
placental histology as described below. Presence of IE in the
intervillous space of the placenta defined PM cases. These were
sub-grouped into PM with or without IV. IV was defined as a
monocyte count $5% of all intervillous cells counted [5].
Uninfected placentas were defined as showing no signs of malaria
infection or intervillositis.
Quantitative PCR analysis of SLC38A1 and SLC38A2 mRNA
expression
RNA was extracted from laser-captured syncytiotrophoblast as
previously described [58]. Briefly, tissue cryosections immobilized
on SuperFrost PLUS slides (Fisher) were air-dried and fixed in
acetone. After rehydration, sections were stained with methyl
green (Sigma-Aldrich) and dehydrated. Material captured by laser
microdissection using a MicroBeam microscope (P.A.L.M. Micro-
laser Technologies) was catapulted directly into RNA extraction
buffer (RLT buffer with b-mercaptoethanol; Qiagen), and RNA
extracted using an RNeasy Micro Kit (Qiagen), according to the
supplier’s recommendations. Purified RNA was eluted and kept at
280uC. RNA (10 ng) was reverse transcribed using Superscript III
enzyme mix (Invitrogen) with random hexamers. Transcript levels
for SLC38A1 (SNAT1), SLC38A2 (SNAT2) and tyrosine 3-
monooxygenase/tryptophan 5-monooxygenase activation protein,
zeta polypeptide (YWHAZ) were quantified using 1:4 dilution of
cDNA for all samples. Primer sequences are shown in Table 4.
Real-time quantitative PCR was performed using previously
reported thermal cycling conditions at an annealing temperature
of 60uC with SYBR Green 1 (Applied Biosystems) [59]. Transcript
levels were quantified against a standard curve generated from a
pool of all placental cDNA samples. Preliminary studies confirmed
YWHAZ transcript levels were comparable between groups and
YWHAZ was used to normalize target gene transcript levels.
MVM vesicle isolation
Isolation of MVM vesicles from placental biopsies (7.261.6 g)
was performed using magnesium precipitation and differential
centrifugation based on the method of Glazier et al. [60] as
described previously [61] with modifications according to Jimenez
et al. [62] to allow simultaneous recovery of the basal plasma
membrane for other studies.
Frozen placental biopsies were thawed and homogenized in
250 mM sucrose, 10 mM HEPES-Tris, pH 6.95 (Buffer D; 2.5
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volumes biopsy weight) and a sample of the homogenate (1 ml)
was retained for further analysis. The remaining homogenate was
centrifuged at 10000 g for 15 min at 4uC and the supernatant
retained. The pellet was resuspended in buffer D (1.5 volumes of
initial biopsy weight) and the centrifugation step was repeated.
The supernatants were pooled and centrifuged at 125000 g for
30 min at 4uC. The pellet was resuspended in buffer D and
12 mM MgCl2 added and stirred on ice for 20 min. The
suspension was centrifuged at 2500 g for 10 min at 4uC. The
supernatant (containing MVM) was centrifuged at 125000 g for
30 min at 4uC. The pellet was resuspended in 300 mM sucrose,
20 mM Tris-maleate, pH 7.4 and loaded onto a discontinuous
25%–37%–45% sucrose gradient. After centrifugation at 90000 g
for 6 h at 4uC, the MVM fraction at the 37%–45% interface was
recovered and centrifuged at 110000 g for 30 min at 4uC. The
resultant MVM pellet was resuspended in intravesicular buffer
(290 mM sucrose, 5 mM HEPES, 5 mM Tris-HCl, pH 7.4; 3
volumes pellet weight) and repeatedly passed through a 25-gauge
needle to vesiculate the MVM fragments to form vesicles. MVM
vesicles were stored at 280uC.
Protein concentration of placental homogenate and MVM
vesicles was determined by the Lowry method [63]. Purity of
MVM vesicle preparations was assessed by enrichment of alkaline
phosphatase activity as described previously [60]. Alkaline
phosphatase enrichment factors (mean 6 SD) were not different
(p = 0.39) between uninfected (16.868.6; n = 18), PM (11.566.0;
n = 14) and PM with IV (12.966.7; n= 21) groups, suggesting
comparable MVM purity between groups.
14C-MeAIB uptake
14C-MeAIB (NEC-671; PerkinElmer,) was used as a well-
characterized, non-metabolizable amino acid analogue substrate
to measure the activity of system A amino acid transporter [15,17].
MVM vesicles. 14C-MeAIB uptake by MVM vesicles was
measured as described previously in the presence and absence of
an inwardly-directed Na+ gradient with the Na+-dependent
component taken to reflect system A-mediated MeAIB uptake
[17]. Uptake was initiated by the addition of 20 ml MVM vesicle
suspension (,430 mg protein) to 20 ml extravesicular buffer (5 mM
HEPES, 5 mM Tris, 145 mM NaCl or 145 mM KCl, 0.165 mM
14C-MeAIB, pH 7.4). Na+-dependent uptake of 14C-MeAIB into
MVM vesicles at 30 s was taken to provide an estimate of initial
rate, in accordance with previous studies [17,19].
BeWo cells. The BeWo choriocarcinoma trophoblast cell line
(kindly provided by Prof Robin Mortimer, Placental Transport
Unit, Queensland Institute of Medical Research, Australia) was
cultured in DMEM/Ham’s F12 medium, supplemented with 10%
fetal bovine serum and penicillin/streptomycin (all from Gibco).
The cells were passaged every 4–7 days and passages 12–30 were
used. Cells were seeded in 24-well culture plates at 2.56105 cells/
well in 0.5 ml culture medium for 24 h at 37uC before the culture
medium was replaced by the stimuli. After 16 h, supernatants
were aspirated, and cells were washed with 0.5 ml transport buffer
(25 mM HEPES, 25 mM Tris, 140 mM NaCl, 5.4 mM KCl,
1.8 mM CaCl2, 0.8 mM MgSO4 and 5 mM glucose, pH 7.5) at
37uC. Then, 0.25 ml transport buffer containing 0.25 mCi 14C-
MeAIB was added to each well for 20 min in 5% CO2 in air at
37uC. In parallel, transport of MeAIB by Na+-independent
pathways was measured, using a modified transport buffer, in
which KCl was substituted for NaCl. Transport buffer was
aspirated and cells washed thrice with ice-cold transport buffer and
lysed in 0.6 ml 1% SDS in 0.2 M NaOH. Lysates were stored at
220uC until the radioactivity was quantified by liquid scintillation
counting in 5 ml Optiphase Hisafe 2 (PerkinElmer) and the lysate
protein concentration was measured by Lowry assay. In parallel,
the impact of stimuli on cell viability was assessed by using the
Alamar Blue assay (Invitrogen) according to the manufacturer’s
instructions [64].
IL-1b ELISA
Placental blood was aspirated from an incision made in the
basal plate at a pericentral site of the placenta. Plasma was
separated and frozen at 280uC. IL-1b was measured by ELISA
(DuoSet, R&D) in undiluted plasma samples according to the
manufacturer’s instructions.
Monocyte/IE co-culture
Monocyte isolation and P. falciparum culture. Buffy
coats from volunteer blood donors (Australian Red Cross Blood
Services) were used to isolate CD14+ cells by positive immuno-
selection using anti-CD14 magnetic beads (Miltenyi Biotec). The
purity of the CD14+ cells as assessed by flow cytometry was
.95%.
P. falciparum blood stage parasites (CS2 line) were maintained in
O+ erythrocytes (Australian Red Cross Blood Services) at 2–5%
hematocrit in RPMI-HEPES medium supplemented with 0.5%
Albumax II (Gibco) and 25 mM NaHCO3 at 37uC in 1% O2/5%
CO2/94% N2. Cultures were regularly synchronized by sorbitol
treatment [65] and knob-expressing IE were selected by sedimen-
tation on gelatin every 2 weeks [66]. No Mycoplasma contamination
of the cultures was detected by PCR.
Co-culture. CD14+ cells were plated out in 24-well tissue
culture-treated plates (Falcon BD biosciences) at 56105 cells/well
(0.5 ml/well in DMEM/Ham’s F12, 10% FBS with penicillin/
streptomycin). Cells were incubated at 37uC in 5% CO2 in air for
1 h before 0.5 ml gelatin-purified IE were added (20 IE per
CD14+ cell). An equal number of uninfected erythrocytes (UE)
were added to control wells. After 24 h, supernatants were
collected, spun at 2000 g for 5 min and cell-free supernatants
stored at 280uC.
Measurement of free amino acids
Samples from primigravidae were preferentially selected for the
amino acid analysis, as they are at highest risk of malaria in
Table 4. Primer sequences used for qPCR.
Target Gene Forward primer Reverse primer
SLC38A1 AAGAAACAGGCTGCATGGTGTA CCCTGTGGTGCCAAAGACTT
SLC38A2 TTCAGTTGGTGGCGTCATAGT AATCAACATAGAAGCTGCAGATGC
YWHAZ ACTTTTGGTACATTGTGGCTTCAA CCGCCAGGACAAACCAGTAT
All sequences are 59-39.
doi:10.1371/journal.ppat.1003153.t004
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pregnancy [2]. In paired maternal and cord blood plasma samples,
free forms of the common 20 amino acids were analyzed by
reversed phase ultra performance liquid chromatography (RP-
UPLC) with pre-column derivatization with 6-aminoquinolyl-N-
hydroxysuccinimidyl carbamate (AccQ Tag Ultra; Waters Cor-
poration). Standards (Amino Acid Standard H (Pierce) together
with Gln, Trp and Asn (Sigma)) were prepared with norvaline
(Sigma) included as an internal standard. For assay, 100 ml plasma
was mixed with an equal volume of 200 mM norvaline and
deproteinated by ultrafiltration through a 10 kDa MWCO spin
filter (Millipore) at 4800 g for 60 min at 10uC. 10 ml filtrate was
derivatized and analyzed on a Waters Acquity UPLC over a
20 min gradient using a 2.16150 mm, 1.7 mm i.d., BEH C18
column (Waters Corporation) flowing at 0.6 ml/min at 60uC.
Detection was via UV (260 nm) and data was collected and
analyzed using the Waters Empower2 software.
Statistical analysis
Non-normally distributed data are presented as box plots
showing the median, 25th/75th and 10th/90th centiles unless
described otherwise. Values out of the 10th centiles were included
in statistical analyses but not represented in graphs. Normally
distributed values are presented as mean and standard deviation.
Non-normally distributed data were normalized by log-transfor-
mation prior to statistical analysis. Data were then compared
between 3 groups using one-way ANOVA. When the p value of
the ANOVA test was lower than 0.1, two-group comparisons were
made using a 2-tailed T-test. Correlations were assessed using
Pearson’s correlation test. Trends across ordered groups were
tested using Cuzick’s test. The ability of the placenta to
concentrate amino acids in cord blood was examined by testing
if the cord to maternal concentration ratio of each amino acid was
different from 1 using a one-sample T-test.
Study approval
The College of Medicine Research Ethics Committee, Univer-
sity of Malawi, approved the study and written informed consent
was obtained from all participants prior to inclusion in the study.
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